Financial Information

Consolidated Balance Sheet

Net Assets(¥ million)
		118th period	119th period
Settlement Date		March 2022	March 2023
Stockholders' Equity		38,000	39,562
Breakdown	Capital	5,451	5,451
	Capital Surplus	4,186	4,186
	Retained Earnings	28,377	30,127
	Treasury Stock	△15	△203
Accumulated Other Comprehensive Income		960	1,041
Breakdown	Valuation Difference on Other Securities	234	223
	Foreign Currency Translation Adjustment Account	△66	10
	Accumulated Adjustment for Retirement Benefits	792	807
Total Net Assets		38,961	40,603
Total Liabilities and Net Assets		64,427	69,123

(¥ million)
	118th period	119th period
Month of settlement	March 2022	March 2023
Net sales	43,134	45,560
Cost of sales	29,638	32,586
Gross profit	13,496	12,974
Selling, general and administrative expenses	11,046	11,365
Other income	236	284
Other expenses	124	145
Ordinary income	2,561	1,748
Extraordinary income	-	1,683
Extraordinary loss	-	-
Income before income taxes	2,561	3,431
Corporate tax, etc	751	1,059
Net income	1,809	2,371
Net income attributable to non-controlling shareholders	-	-
Net income attributable to owners of parent	1,809	2,371

(¥ million)
	118th period	119th period
Month of settlement	March 2022	March 2023
Cash flows from operating activities	4,064	2,917
Cash flows from investing activities	△2,898	△1,153
Cash flows from financing activities	△691	△867
Exchange differences on cash and cash equivalents	25	11
Change in cash and cash equivalents	499	908
Cash and cash equivalents at beginning of year	13,344	13,844
Cash and cash equivalents at end of year	13,844	14,752